CF33 clearly works in the Petrie dish. But replicating that success in humans is proving far harder.
The problem isn’t the virus itself, but how it’s delivered.In real patients, especially with multiple tumours, getting the virus to each site in the right amount, and the right time, seems technically difficult.
I think this is the reality check that management hasn’t clearly communicated to investors.
Azer-cel was meant to be the agent that worked with onCARlytics to attack solid tumours. Good thing it’s working in blood cancers. Hopefully we see more complete responses. .
Just my interpretation of events as I see them. DYOR.
IMU Price at posting:
1.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)